Capricor Therapeutics Inc
CAPRHealthcare|Biotechnology|USA
$21.50
-0.99 (-4.40%)
Tangible Book
$4.83
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Awaiting Results (2)
Trials past primary completion date but still active — data readout may be imminent.
Jun 2025
P3
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
NCT05126758